ARTICLE | Company News
Chiron, BMY HCV license deal
November 27, 2001 8:00 AM UTC
CHIR granted Bristol-Myers Squibb (BMY) a non-exclusive license to its patents covering the screening of small molecules that inhibit hepatitis C virus (HCV) targets. The license expands a 1997 deal u...